Lesley Stolz PhD, BSc

Lesley is the Head of JLABS California including JLABS @ SSF, JLABS @ QB3 and our flagship JLABS San Diego. In this role, Lesley is responsible for external engagement, innovation sourcing, company onboarding, portfolio management, operational excellence, educational programming and P&L. In this role, she catalyzes and support the translation of science and technology into valuable solutions for patients and consumers across the pharmaceutical, medical device and consumer healthcare sectors.
Prior to JLABS, Lesley was Head of Transactions at Johnson & Johnson Innovation in Menlo Park. She has been working in corporate and business development roles for the last 17 years for companies that are both technology platform and therapeutics focused. Her most recent executive positions have been with BioTime, a publicly traded stem cell technology and therapeutic company, and Sutro Biopharma, a platform technology company working in cell-free protein synthesis. Prior to Sutro, Lesley served in BD positions for a number of biotech companies in the U.S. and Europe.
Lesley received her Ph.D. in chemistry, and conducted postdoctoral research at Harvard Medical School’s Department of Biochemistry and Molecular Pharmacology.